Constantino Michael T.
SEC insider (Form 3/4/5 filer). CIK 0001817285. Director at Humacyte, Inc. (HUMA). 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in DURHAM, NC.
Companies Constantino Michael T. has filed insider reports for
- Humacyte, Inc. (HUMA): Director
Constantino Michael T.
CIK: 0001817285
Transaction Breakdown
Open Market Buys (P)3 (60.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HUMA
Humacyte, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 11, 2026HUMA
Humacyte, Inc.
AwardDirectStock Options (right to buy)
80K shares- - May 18, 2026HUMA
Humacyte, Inc.
PurchaseDirect11K shares at avg. $0.89$10K - Jun 12, 2025HUMA
Humacyte, Inc.
AwardDirectStock Options (right to buy)
80K shares- - Apr 7, 2025HUMA
Humacyte, Inc.
PurchaseDirect16K shares at avg. $1.26$20K - Dec 4, 2024HUMA
Humacyte, Inc.
PurchaseDirect4.6K shares at avg. $4.39$20K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 | HUMA Humacyte, Inc. | Award Stock Options (right to buy) | 80,000 | - | - | Direct |
| May 18, 2026 | HUMA Humacyte, Inc. | Purchase | 11,000 | $0.89 | $9,840 | Direct |
| Jun 12, 2025 | HUMA Humacyte, Inc. | Award Stock Options (right to buy) | 80,000 | - | - | Direct |
| Apr 7, 2025 | HUMA Humacyte, Inc. | Purchase | 16,000 | $1.26 | $20,160 | Direct |
| Dec 4, 2024 | HUMA Humacyte, Inc. | Purchase | 4,600 | $4.39 | $20,181 | Direct |
1-5 of 5 transactions